肺炎球菌结合疫苗诱导的IgG与肺炎球菌鼻咽部携带:低应答与针对携带的免疫保护相关物
本研究对肯尼亚两项已发表肺炎球菌结合疫苗(PCV)安全性和免疫原性临床试验数据进行二次分析,比较接种时同血清型携带者与非携带者的疫苗应答,并评估PCV诱导的血清IgG水平与携带获得风险的关系。结果发现新生儿携带者的免疫应答较非携带者低51%–82%,幼儿携带者中6B、14和19F血清型接种后应答低29%–70%;估计的针对携带获得的保护相关物(CoP)为0.26–1.93μg/mL,但这些阈值在统计学上无法与恒定携带概率模型区分。
要点
- 新生儿中,携带者的免疫应答较非携带者低51%–82%,因血清型而异。
- 幼儿中6B、14和19F血清型携带者接种后应答较非携带者低29%–70%。
- 估计的针对携带获得的CoP为0.26–1.93μg/mL,但统计学上无法与恒定携带概率模型区分。
核心结论
- 在赤道非洲地区婴儿和幼儿中证实了低应答现象。
- 随着疫苗血清型携带率降低,人群对疫苗的应答可能随时间改善。
- 在该人群幼儿中未发现明确的针对携带获得的保护相关物。
- 由于缺乏明确的血清型特异性保护相关物,通过针对携带的CoP评估新疫苗潜力仍然困难。
研究设计与样本
- 对肯尼亚两项已发表的PCV安全性和免疫原性临床试验数据进行二次分析。
- 比较接种时同血清型携带者与非携带者对疫苗接种的应答。
- 采用阶梯或连续风险函数评估PCV诱导的血清IgG水平与携带获得风险的关系。
主要发现
- 新生儿中,携带者的免疫应答较非携带者低51%–82%,因血清型而异。
- 幼儿中,6B、14和19F血清型携带者接种后应答较非携带者低29%–70%。
- 估计的针对携带获得的CoP为0.26–1.93μg/mL,因血清型而异。
- 这些阈值在统计学上无法与恒定携带概率模型区分。
关键数值与推荐
- 新生儿携带者免疫应答较非携带者低51%–82%。
- 幼儿6B、14和19F血清型携带者接种后应答较非携带者低29%–70%。
- 针对携带获得的CoP估计范围为0.26–1.93μg/mL。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior studies have demonstrated hyporesponsiveness to pneumococcal conjugate vaccines (PCVs) when administered in the presence of homologous carriage. This may be substantially more important in Africa where carriage prevalence is high. Deriving a correlate of protection (CoP) for carriage is important in guiding the future use of extended PCVs as population control of pneumococcal disease by vaccination is now focused principally on its indirect effect. We therefore explored the complex relationship between existing carriage and vaccine responsiveness, and between serum IgG levels and risk of acquisition. METHODS: We undertook secondary analyses of data from two previously published clinical trials of the safety and immunogenicity of PCV in Kenya. We compared responses to vaccination between serotype-specific carriers and non-carriers at vaccination. We assessed the risk of carriage acquisition in relation to PCV-induced serum IgG levels using either a step- or continuous-risk function. RESULTS: For newborns, the immune response among carriers was 51-82% lower than that among non-carriers, depending on serotype. Among toddlers, for serotypes 6B, 14 and 19F the post-vaccination response among carriers was lower by between 29 and 70%. The estimated CoP against acquisition ranged from 0.26 to 1.93μg/mL across serotypes, however, these thresholds could not be distinguished statistically from a model with constant probability of carriage independent of assay value. CONCLUSION: We have confirmed hyporesponsiveness in an equatorial African setting in both infants and toddlers. Population responses to vaccination are likely to improve with time as carriage prevalence of vaccine serotypes is reduced. We have not found clear correlates of protection against carriage acquisition among toddlers in this population. Assessing the potential of new vaccines through the use of CoP against carriage is still difficult as there are no clear-cut serotype specific correlates.
引用
- Ojal J, Hammitt LL, Gaitho J, et al. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage. Vaccine. 2017. PMID: 28739116. doi:10.1016/j.vaccine.2017.05.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。